InsidersTradesSigma
Follow the Shanghai Junshi Biosciences Co., Ltd. share price and the full directors' dealings record of the company, a publicly traded company based in Hong Kong. Shares are listed on the HK market, under the authority of HKEX. Operating in the Health Care sector, Shanghai Junshi Biosciences Co., Ltd. has logged 5 insider filings. Market capitalisation: €18.7bn. The latest transaction was filed on 8 April 2026 (Purchase). Among the most active insiders: Xiong Jun. Every trade is openly available.
5
Insider Decl.
n/a
Thresholds
€11m
5 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Shanghai Junshi Biosciences Co., Ltd. Strong Buy (bullish), based on 4 analysts. Average price target: HK$28.93.
15Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 23,748 of 29,063 companies
29.4
score / 100
Value21
Quality38
FCF yld-6.8%
Earn yld-4.5%
EV/EBITDA·
ROE-13%
Gross mgn79%
Net mgn-34%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 8 April 2026
Declarations5 total
894,600 sharesShareXHKGHKEX:DA20260403E00027
1,999,513 sharesShareXHKGHKEX:DA20260403E00026
5 of 5 declarations
关于 Shanghai Junshi Biosciences Co., Ltd.
Shanghai Junshi Biosciences Co., Ltd. 是一家生物制药公司，专注于创新药物的研发。它专注于用于治疗严重疾病的生物疗法。